Rossari Biotech Declares Unaudited Q2 FY27 Results

Rossari Biotech Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which were reviewed by the Audit Committee and subjected to a limited review by the Statutory Auditors. Additionally, the Board approved the leasing of land by its wholly-owned subsidiary, Rossari International Limited, for a new greenfield manufacturing facility in Saudi Arabia. Further details on the project plan and investment will be disclosed upon finalization.